These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7194584)

  • 41. Menstrual pattern changes in laparoscopic sterilization patients whose last pregnancy was terminated by therapeutic abortion. A two-year follow-up study.
    Kwak HM; Chi I; Gardner SD; Laufe LE
    J Reprod Med; 1980 Aug; 25(2):67-71. PubMed ID: 7411527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Norplant and its side effects].
    Kato K; Joachim A; Nielsen P; Habib ND
    Zentralbl Gynakol; 1995; 117(5):260-2. PubMed ID: 7793168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The state of the contraceptive art.
    Tyrer LB; Duarte J
    Plan Parent Rev; 1983; 3(2):5-7. PubMed ID: 12265618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A difficult and delicate task: prescribing contraception for adolescents].
    Abranches AD
    Planej Agora; 1993 Mar; 9(233):3. PubMed ID: 12318748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral contraceptives: Pt. 2.
    Family Planning Association of New South Wales
    Fam Plann Inf Serv; 1978; 1(2):1-36. PubMed ID: 12338652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menstrual bleeding changes with different contraceptive methods.
    Contracept Rep; 1997 Nov; 8(5 Suppl):1-2. PubMed ID: 12293020
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cycle control and side effects of a new combiphasic oral contraceptive regimen.
    Dieben TO; op ten Berg MT; Coelingh Bennink HJ
    Arzneimittelforschung; 1994 Jul; 44(7):877-9. PubMed ID: 7945527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gestodene: clinical experience with an innovative progestogen used in a combination oral contraceptive preparation.
    Merchiers E; Thiery M; Van Kets H; Parewijck W; Defoort P; Martens G
    Acta Ther; 1990; 16(2):129-38. PubMed ID: 12342969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hysterographic orientation of IUDs in relation to menstrual blood loss.
    Kandil O; Aref I; El-sheikha Z; Radwan MM; El-agizi H; Hassanein MK
    Contracept Deliv Syst; 1983 Jul; 4(3):213-7. PubMed ID: 12265365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Drug-induced anovulation and possible endocrine consequences].
    Gitsch E
    Wien Klin Wochenschr; 1968 Feb; 80(5):81-3. PubMed ID: 5667718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use multiple strategies to manage common pill side effects.
    Contracept Technol Update; 1988 Jul; 9(7):77-81. PubMed ID: 12281576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Amenorrhea following the administration of oral contraceptives].
    Gertrudis Diez MA
    Acta Ginecol (Madr); 1984 Apr; 41(4):201-6. PubMed ID: 12267262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diagnostic investigation of clients seeking contraception in a general practive. Diagnostic probability for pronounced menstrual discomfort, sexual complaints and pathological gynecologic findings in a woman's age, marrital status, parity, employment, and social status].
    Kragstrup J
    Ugeskr Laeger; 1977 May; 139(21):1232-5. PubMed ID: 559364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Behavior of heparinocytes and of fibrinolytic degradation products after discontinuation of hormonal contraceptives].
    Frick G; Göretzlehner G; Frick U
    Zentralbl Gynakol; 1976; 98(15):908-13. PubMed ID: 969999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Oral contraception and gynecologic therapy].
    Käsemann W
    Med Welt; 1969 Jan; 2():107-10. PubMed ID: 4179615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Adverse effects of hormonal contraception].
    Hauser GA
    Med Klin; 1970 Jul; 65(27):1290-6. PubMed ID: 5534645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapy of secondary effects produced by anovulatory agents].
    Zamarriego Crespo J; Menéndez Sanjurjo A; García Ramos C
    Tokoginecol Pract; 1973 May; 32(323):625-32. PubMed ID: 4802993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Oral contraceptive agents and the fibrinolytic system].
    Nalbanski B; Kamenov V
    Akush Ginekol (Sofiia); 1989; 28(6):51-5. PubMed ID: 2483796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Vestibular side effects of contraceptives].
    Nagymajtényi E; Katona E; Szabados E; Ribári O
    Orv Hetil; 1981 Feb; 122(8):455-7. PubMed ID: 6974842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.